Knuettel II Francis
CIK 1433316 · CFO, Treas & Secty · last filed 2026-06-10
Knuettel II Francis is a CFO, Treas & Secty who has filed 37 SEC Form 4 insider transactions across 8 companies since 2014. The most recent filing, for SBEV, was dated Jun 10, 2026. Across all open-market trades the lifetime net is −$1.7K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $936.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$936.0K
8
37
-$1.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SBEV | Director | — | $0.35 | — | $0 | 1 | 2026-06-10 |
| BLNE | Director | 80,000 | $0.97 | $77.3K | $0 | 3 | 2026-06-01 |
| PTHS | CFO, Treas & Secty | 30,841 | $27.77 | $856.5K | -$40.3K | 3 | 2026-05-26 |
| Pelthos Therapeutics Inc. (CHRO) Delisted | CEO, Pres., CFO, Treas & Secty | 107,822 | $13.50 | $1.46M | $16.0K | 7 | 2025-04-15 |
| FORUM MARKETS Inc (ATNFW) Delisted | Director | 0 | $0.43 | $0 | $0 | 3 | 2023-09-08 |
| SCWorx Corp. (WORX) Delisted | Director | 282 | $0.35 | $99 | $0 | 2 | 2019-11-29 |
| AQMS | Chief Financial Officer | 813 | $2.80 | $2.3K | $22.6K | 1 | 2018-06-18 |
| MARA | CHIEF FINANCIAL OFFICER | — | $11.38 | — | $0 | 1 | 2014-11-05 |
Recent Filings
37 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-10 | SBEV | Grant (A) | — | $0 | EDGAR |
| 2026-06-01 | BLNE | Grant (A) | +10,000 | $0 | EDGAR |
| 2026-05-26 | PTHS | Mixed | −15,447 | -$40.3K | EDGAR |
| 2026-05-22 | PTHS | Notice (144) | −1,720 | -$46.6K | EDGAR |
| 2026-04-01 | PTHS | Grant (A) | +33,472 | $0 | EDGAR |
| 2025-12-17 | BLNE | Grant (A) | +30,000 | $0 | EDGAR |
| 2025-10-06 | BLNE | Grant (A) | +40,000 | $0 | EDGAR |
| 2025-07-07 | PTHS | Grant (A) | — | $0 | EDGAR |
| 2025-07-03 | — | Mixed | +10,000 | $100.0K | |
| 2025-04-15 | Pelthos Therapeutics Inc. (CHRO) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.